Tag Archives: pharmaceutical

Winners of 2016 health journalism contest announced

Pia Christensen

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

In-depth investigations into heroin and pain-pill abuse drew several top awards in this year’s Awards for Excellence in Health Care Journalism.

The 2016 awards, announced today by the Association of Health Care Journalists, recognize the best health reporting in 11 categories. This year, the contest’s 13th, drew nearly 400 entries.

Winning entries included investigations into inflated prescription-drug prices, agricultural practices fueling antibiotic resistance, and poor oversight of dangerous drug interactions.

Read more about the winners.

Skyrocketing drug prices put seniors’ health at risk

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in Kaiser Health News, The Atlantic.com, New America Media, AARP.com and other outlets. She is a senior fellow at the Center for Health, Media & Policy at Hunter College in New York City, and co-produces HealthStyles for WBAI-FM/Pacifica Radio.

Photo: Frankieleon via Flickr

Photo: Frankieleon via Flickr

The average price of brand-name prescription drugs rose almost 130 times faster than inflation in 2015 — 15.5 percent compared with 0.1 percent. New data points to increasing medication affordability problems for older adults, putting many of them at risk, according to a new report.

Researchers from the AARP Public Policy Institute studied trends in the retail prices of 268 brand name drugs widely used by older Americans between 2006 and 2015. Continue reading

How will the election affect the business of health care?

Joanne Kenen

About Joanne Kenen

Joanne Kenen, (@JoanneKenen) the health editor at Politico, is AHCJ’s topic leader on health reform and curates related material at healthjournalism.org. She welcomes questions and suggestions on health reform resources and tip sheets at joanne@healthjournalism.org.

trump-post-election

Donald J. Trump

The Washington Post has taken a post-election look at 15 major industries in a story aptly titled, “Mr. Business Goes to Washington. NOW WHAT?” The overview was written by Thomas Heath, with health care industry input from Carolyn Johnson.

The Post story divided industries into “winners” (assuming no major recession) and “it’s complicated.” Health care – naturally – fell under “complicated.” Continue reading

Turn to new tip sheet before writing about drug prices

Joanne Kenen

About Joanne Kenen

Joanne Kenen, (@JoanneKenen) the health editor at Politico, is AHCJ’s topic leader on health reform and curates related material at healthjournalism.org. She welcomes questions and suggestions on health reform resources and tip sheets at joanne@healthjournalism.org.

Photo: pixxiestails via Flickr

Photo: pixxiestails via Flickr

Drug prices have become a hot topic – and a significant source of the ongoing challenges to achieving affordable premiums and out-of-pocket costs in both Affordable Care Act exchange plans and employer-sponsored coverage. Drug costs are now the single largest health care concern of Americans across the political spectrum, according to some polls.

But it can be hard to know where to go to find out information about drug pricing and drug value (which aren’t the same thing). Continue reading

Chicago panel explores the world of drug pricing

Carla K. Johnson

About Carla K. Johnson

Carla K. Johnson (@CarlaKJohnson) is a medical writer at The Associated Press and has covered health and medicine since 2001. A former member of AHCJ's board of directors, she leads the Chicago AHCJ chapter.

Photo: Carla K. JohnsonCraig Garthwaite, assistant professor, Northwestern University's Kellogg School of Management (left); Roy Guharoy, Pharm.D. vice president and chief pharmacy officer for the Resource Group at Ascension (middle); and independent journalist and AHCJ member Duncan Moore (right) spoke at the Chicago chapter event “Drug Pricing: Covering the Controversy” at Columbia College in Chicago on Feb. 23.

Photo: Carla K. JohnsonCraig Garthwaite, assistant professor, Northwestern University’s Kellogg School of Management (left); Roy Guharoy, Pharm.D. vice president and chief pharmacy officer for the Resource Group at Ascension (middle); and independent journalist and AHCJ member Duncan Moore (right) spoke at the Chicago chapter event “Drug Pricing: Covering the Controversy” at Columbia College in Chicago on Feb. 23.

A blockbuster hepatitis C drug costs $84,000, straining state budgets. Martin Shkreli acquires the rights to a generic and raises its price 5,000 percent. Presidential candidates react to the public outcry, claiming they know what to do about the drug prices.

What does it all mean? Until recently, “there’s been an equilibrium in the public mind between a free market regimen of the market setting prices and what the public and payers are willing to pay,” said independent journalist Duncan Moore,  “but there are indications this informal tradeoff has begun to swing out of control.” Continue reading